CMC Fundamental Analysis - JPMORGAN CHASE & CO

Fundamental Rating

CMC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 98 industry peers in the Banks industry. While CMC is still in line with the averages on profitability rating, there are concerns on its financial health. CMC is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

CMC had positive earnings in the past year.

CMC had a negative operating cash flow in the past year.

Each year in the past 5 years CMC has been profitable.

The reported operating cash flow has been mixed in the past 5 years: CMC reported negative operating cash flow in multiple years.

1.2 Ratios

CMC's Return On Assets of 1.21% is amongst the best of the industry. CMC outperforms 83.51% of its industry peers.

Looking at the Return On Equity, with a value of 15.45%, CMC belongs to the top of the industry, outperforming 83.51% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	1.21%
ROE	15.45%
ROIC	N/A

ROA(3y)1.21%

ROA(5y)1.14%

ROE(3y)14.45%

ROE(5y)13.79%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CMC's Profit Margin of 31.40% is amongst the best of the industry. CMC outperforms 81.44% of its industry peers.

CMC's Profit Margin has been stable in the last couple of years.

CMC does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	31.4%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-5.73%

PM growth 5Y1.36%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CMC does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for CMC has been reduced compared to 1 year ago.

CMC has less shares outstanding than it did 5 years ago.

The debt/assets ratio for CMC is higher compared to a year ago.

2.2 Solvency

CMC has a Debt/Equity ratio of 3.03. This is a high value indicating a heavy dependency on external financing.

With a Debt to Equity ratio value of 3.03, CMC is not doing good in the industry: 68.04% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	3.03
Debt/FCF	N/A
Altman-Z	N/A

ROIC/WACCN/A

WACC10.89%

2.3 Liquidity

		Industry Rank	Sector Rank
Current Ratio	N/A
Quick Ratio	N/A

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CMC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.30%, which is quite good.

The Earnings Per Share has been growing by 11.43% on average over the past years. This is quite good.

CMC shows a small growth in Revenue. In the last year, the Revenue has grown by 2.97%.

Measured over the past years, CMC shows a quite strong growth in Revenue. The Revenue has been growing by 8.94% on average per year.

EPS 1Y (TTM)17.3%

EPS 3Y5.01%

EPS 5Y11.43%

EPS Q2Q%16.43%

Revenue 1Y (TTM)2.97%

Revenue growth 3Y13.43%

Revenue growth 5Y8.94%

Sales Q2Q%-10.42%

3.2 Future

Based on estimates for the next years, CMC will show a small growth in Earnings Per Share. The EPS will grow by 6.30% on average per year.

The Revenue is expected to grow by 1.75% on average over the next years.

EPS Next Y10.56%

EPS Next 2Y7.27%

EPS Next 3Y7.54%

EPS Next 5Y6.3%

Revenue Next Year1.09%

Revenue Next 2Y1.87%

Revenue Next 3Y2.59%

Revenue Next 5Y1.75%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.33, the valuation of CMC can be described as correct.

Based on the Price/Earnings ratio, CMC is valued expensively inside the industry as 88.66% of the companies are valued cheaper.

When comparing the Price/Earnings ratio of CMC to the average of the S&P500 Index (27.86), we can say CMC is valued slightly cheaper.

A Price/Forward Earnings ratio of 15.12 indicates a correct valuation of CMC.

Based on the Price/Forward Earnings ratio, CMC is valued a bit more expensive than 79.38% of the companies in the same industry.

Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, CMC is valued a bit cheaper.

		Industry Rank	Sector Rank
PE	16.33
Fwd PE	15.12

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

CMC's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

PEG (NY)1.55

PEG (5Y)1.43

EPS Next 2Y7.27%

EPS Next 3Y7.54%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CMC!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

JPMORGAN CHASE & CO

FRA:CMC (10/3/2025, 7:00:00 PM)

264.65

+2.1 (+0.8%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupBanks

GICS IndustryBanks

Earnings (Last)07-15 2025-07-15/bmo

Earnings (Next)10-14 2025-10-14/bmo

Inst Owners74.26%

Inst Owner ChangeN/A

Ins Owners0.38%

Ins Owner ChangeN/A

Market Cap727.72B

Analysts73.33

Price Target270.23 (2.11%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend4.44

Dividend Growth(5Y)6.07%

DP28.18%

Div Incr Years6

Div Non Decr Years6

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)7.47%

Min EPS beat(2)5.36%

Max EPS beat(2)9.57%

EPS beat(4)4

Avg EPS beat(4)9.7%

Min EPS beat(4)5.36%

Max EPS beat(4)15.92%

EPS beat(8)7

Avg EPS beat(8)6.2%

EPS beat(12)11

Avg EPS beat(12)10.73%

EPS beat(16)14

Avg EPS beat(16)9.89%

Revenue beat(2)2

Avg Revenue beat(2)2.97%

Min Revenue beat(2)2.66%

Max Revenue beat(2)3.28%

Revenue beat(4)4

Avg Revenue beat(4)3.18%

Min Revenue beat(4)2.66%

Max Revenue beat(4)3.77%

Revenue beat(8)7

Avg Revenue beat(8)1.96%

Revenue beat(12)10

Avg Revenue beat(12)2.41%

Revenue beat(16)10

Avg Revenue beat(16)1.14%

PT rev (1m)-0.71%

PT rev (3m)8.92%

EPS NQ rev (1m)0.53%

EPS NQ rev (3m)5.44%

EPS NY rev (1m)0.27%

EPS NY rev (3m)6.81%

Revenue NQ rev (1m)0.17%

Revenue NQ rev (3m)2.3%

Revenue NY rev (1m)0.03%

Revenue NY rev (3m)1.96%

Valuation

		Industry Rank	Sector Rank
PE	16.33
Fwd PE	15.12
P/S	4.87
P/FCF	N/A
P/OCF	N/A
P/B	2.4
P/tB	2.92
EV/EBITDA	N/A

EPS(TTM)16.21

EY6.13%

EPS(NY)17.5

Fwd EY6.61%

FCF(TTM)-45.98

FCFYN/A

OCF(TTM)-45.98

OCFYN/A

SpS54.34

BVpS110.43

TBVpS90.49

PEG (NY)1.55

PEG (5Y)1.43

Profitability

		Industry Rank	Sector Rank
ROA	1.21%
ROE	15.45%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	31.4%
GM	N/A
FCFM	N/A

ROA(3y)1.21%

ROA(5y)1.14%

ROE(3y)14.45%

ROE(5y)13.79%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-5.73%

PM growth 5Y1.36%

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0.04

Health

		Industry Rank	Sector Rank
Debt/Equity	3.03
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	N/A
Quick Ratio	N/A
Altman-Z	N/A

F-Score3

WACC10.89%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)17.3%

EPS 3Y5.01%

EPS 5Y11.43%

EPS Q2Q%16.43%

EPS Next Y10.56%

EPS Next 2Y7.27%

EPS Next 3Y7.54%

EPS Next 5Y6.3%

Revenue 1Y (TTM)2.97%

Revenue growth 3Y13.43%

Revenue growth 5Y8.94%

Sales Q2Q%-10.42%

Revenue Next Year1.09%

Revenue Next 2Y1.87%

Revenue Next 3Y2.59%

Revenue Next 5Y1.75%

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-1488.11%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-1488.11%

OCF growth 3YN/A

OCF growth 5YN/A

JPMORGAN CHASE & CO (CMC.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens